Search / Trial NCT06222216

The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults

Launched by TC ERCIYES UNIVERSITY · Jan 22, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether using a chilled needle can help reduce pain and bruising (called ecchymosis) during subcutaneous injections, which are commonly given under the skin. These injections are often performed by nurses and can sometimes be painful or lead to complications like bruising, causing anxiety for patients. The researchers believe that cooling the needle before the injection might make the process more comfortable and could prevent these side effects.

To participate in this study, you need to be between 18 and 65 years old, able to understand Turkish, and not currently taking certain medications that could affect your participation. You should also not have had a subcutaneous injection in the last month. If you join the study, you'll receive specific instructions on what to expect during the injection process. This trial is still recruiting participants, and it aims to find a simple and effective way to improve the experience of receiving injections.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Able to speak and understand Turkish,
  • 2. Those between the ages of 18-65,
  • 3. Oriented to place and time,
  • 4. Having no vision or hearing problems,
  • 5. Not using psychiatric medication due to any psychiatric disease,
  • 6. Not using central nervous system medication,
  • 7. Not using narcotic analgesics,
  • 8. Having a Visual Comparison Scale pain score of zero at the time of application,
  • 9. Those who have not had SC injection in the last month,
  • 10. Low molecular weight heparin therapy is ordered (Enoxaparin Sodium 1\*4000 IU),
  • 11. Having an average pressure pain threshold of 8-16 pounds (Lb) with the Baseline Algometer device,
  • 12. Has normal platelet, INR, and aPTT values,
  • 13. Individuals who volunteer to participate in the study and sign the written voluntary consent form will be included in the research.
  • Exclusion Criteria:
  • 1. Vital signs not within the reference range,
  • 2. Those with signs of phlebitis, scar tissue, dermatitis, incision and infection in the area where the intervention will be performed,
  • 3. Having had a mastectomy,
  • 4. Patients who declare that they are addicted to alcohol and drugs will not be included in the research.

About Tc Erciyes University

TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.

Locations

Kayseri, Talas, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0